Structures by: Farrell D. M.
Total: 38
N,N'-Dimethylpiperazine--(S)-malic acid (1/2)
C6H16N2,2(C4H5O5)
Acta Crystallographica, Section B (2002) 58, 3 530-544
a=5.8757(3)Å b=7.8751(4)Å c=10.6165(7)Å
α=70.345(2)° β=74.500(2)° γ=87.435(3)°
4,4'-Bipyridyl--(S)-malic acid (1/1),triclinic polymorph
C10H8.5N2,C4H5.5O5
Acta Crystallographica, Section B (2002) 58, 3 530-544
a=5.1647(4)Å b=6.2749(5)Å c=10.2126(9)Å
α=83.235(3)° β=89.808(3)° γ=79.601(3)°
4,4'-Bipyridyl--(S)-malic acid (1/1), monoclinic polymorph
2(C10H8.5N2),2(C4H5.5O5)
Acta Crystallographica, Section B (2002) 58, 3 530-544
a=20.500(4)Å b=4.6656(9)Å c=14.201(3)Å
α=90.00° β=99.68(3)° γ=90.00°
4,4'-Bipyridyl--racemic malic acid (1/1)
C10H8.5N2,C4H5.5O5
Acta Crystallographica, Section B (2002) 58, 3 530-544
a=14.1274(8)Å b=4.7459(3)Å c=20.1749(13)Å
α=90.00° β=100.565(3)° γ=90.00°
1,2-Bis-(4'-pyridyl)ethene--(S)-malic acid (1/1)
C12H11N2,C4H5O5
Acta Crystallographica, Section B (2002) 58, 3 530-544
a=4.9325(3)Å b=8.3343(4)Å c=9.3502(7)Å
α=72.751(2)° β=89.414(2)° γ=80.207(2)°
1,4-Diazabicyclo[2.2.2]octane--racemic malic acid (1/2)
C6H14N2,2(C4H5O5)
Acta Crystallographica, Section B (2002) 58, 3 530-544
a=12.7309(3)Å b=20.9103(5)Å c=12.5400(3)Å
α=90.00° β=95.1780(13)° γ=90.00°
1,2-Bis-(4'-pyridyl)ethene--racemic malic acid (1/1)
2(C6H5N),C4H6O5
Acta Crystallographica, Section B (2002) 58, 3 530-544
a=4.9566(6)Å b=8.4178(10)Å c=9.2538(14)Å
α=73.213(5)° β=89.915(6)° γ=79.750(7)°
Piperazine--(2R,3R)-tartaric acid (1/1)
C4H12N2,C4H4O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=6.4043(3)Å b=9.0860(5)Å c=9.3734(4)Å
α=90.00° β=109.006(3)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--(2R,3R)-tartaric acid (3/4)
2(C6H14N2),C6H13N2,3(C4H5O6),C4H4O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=8.88860(10)Å b=10.0973(4)Å c=45.2601(7)Å
α=90.00° β=90.00° γ=90.00°
N,N'-Dithiodiphthalimide
C16H8N2O4S2
Acta Crystallographica Section B (2002) 58, 2 289-299
a=7.1298(2)Å b=30.7247(13)Å c=6.8691(2)Å
α=90.00° β=90.00° γ=90.00°
N,N'-Dithiodiphthalimide
C16H8N2O4S2
Acta Crystallographica Section B (2002) 58, 2 289-299
a=13.5052(2)Å b=7.87400(10)Å c=29.2050(5)Å
α=90.00° β=98.9640(5)° γ=90.00°
2-Amino-4-benzylamino-6-benzyloxy-5-nitrosopyrimidine
C18H17N5O2
Acta Crystallographica Section B (2002) 58, 2 300-315
a=11.677(2)Å b=13.362(3)Å c=21.478(4)Å
α=90.00° β=102.58(3)° γ=90.00°
Ethyl N-(2-amino-6-benzyloxypyrimidin-4-yl)gylcinate
C15H17N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=7.3525(4)Å b=7.5420(5)Å c=14.9454(13)Å
α=91.797(3)° β=100.467(3)° γ=106.102(6)°
Ethyl N-(2-amino-6 benzyloxy-5-nitrosopyrimidin-4-yl)-β-alaninate
C16H19N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=5.2399(16)Å b=31.1630(14)Å c=9.792(4)Å
α=90.00° β=100.200(12)° γ=90.00°
Ethyl N-(2-amino-6-benzyloxo-5-nitrosopyrimidin-4-yl)-β-alaninate
C16H19N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=7.4830(2)Å b=16.6110(6)Å c=13.5378(6)Å
α=90.00° β=91.5420(11)° γ=90.00°
Ethyl N-(2-amino-6-benzyloxy-5-nitrosopyrimidin-4-yl)-L-phenylalaninate
C22H23N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=7.9899(3)Å b=8.4278(3)Å c=17.0042(7)Å
α=99.9100(12)° β=90.5610(13)° γ=111.4880(17)°
Ethyl N-(2-benzylamino-6-benzyloxy-5-nitrosopyrimidin-4-yl)-β-alaninate
C23H25N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=8.6595(2)Å b=16.3567(4)Å c=16.9014(4)Å
α=105.2210(13)° β=104.6960(13)° γ=100.3720(12)°
4-Benzylamino-2, 6-bis(benzyloxy)-5-nitrosopyrimidine
C25H22N4O3
Acta Crystallographica Section B (2002) 58, 2 300-315
a=14.6856(5)Å b=7.7726(2)Å c=18.5721(8)Å
α=90.00° β=99.8847(13)° γ=90.00°
2-Benzylamino-4,6-bis(benzyloxy)-5-nitrosopyrimidine
C25H22N4O3
Acta Crystallographica Section B (2002) 58, 2 300-315
a=13.8074(3)Å b=15.8175(5)Å c=10.2119(5)Å
α=90.00° β=105.7490(11)° γ=90.00°
2-Amino-4,6-bis(benzyloxy)pyrimidine
C18H17N3O2
Acta Crystallographica Section B (2002) 58, 2 300-315
a=32.4902(9)Å b=7.5034(2)Å c=12.7804(4)Å
α=90.00° β=98.8790(16)° γ=90.00°
1,2-Bis-(4'-pyridyl)ethene--racemic tartaric acid (1/1)
C16H16N2O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=8.8780(11)Å b=9.6130(13)Å c=10.1020(13)Å
α=73.665(7)° β=66.433(8)° γ=79.141(6)°
1,2-Bis-(4'-pyridyl)ethene--(2R,3R)-tartaric acid (1/)
C12H11N2,C12H10N2,C4H6O6,C4H5O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=8.6195(3)Å b=9.5654(4)Å c=9.8727(4)Å
α=103.1622(18)° β=109.9123(18)° γ=90.262(3)°
4,4'-Bipyridyl--racemic tartaric acid (1/1)
C10H9N2,C4H5O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=4.7847(2)Å b=10.2505(5)Å c=13.8412(8)Å
α=99.434(2)° β=91.252(2)° γ=96.163(2)°
4,4'-Bipyridyl--(2R,3R)-tartaric acid (1/1)
C14H14N2O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=10.4430(13)Å b=4.4665(6)Å c=14.110(2)Å
α=90.00° β=92.954(5)° γ=90.00°
Piperazine--racemic tartaric acid (1/2)
C4H12N2,2(C4H5O6)
Acta Crystallographica Section B (2002) 58, 2 272-288
a=6.5439(3)Å b=15.7915(8)Å c=7.5357(4)Å
α=90.00° β=94.484(2)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--racemic tartaric acid (1/2)
(C6H13N2),2(C4H5.5O6)
Acta Crystallographica Section B (2002) 58, 2 272-288
a=7.32400(10)Å b=15.9935(3)Å c=7.51490(10)Å
α=90.00° β=94.4050(11)° γ=90.00°
N,N'-Dithiodiphthalimide--nitromethane solvate (1/1)
C16H8N2O4S2,C1H3N1O2
Acta Crystallographica Section B (2002) 58, 2 289-299
a=22.5545(9)Å b=4.8545(2)Å c=16.7095(14)Å
α=90.00° β=102.4670(17)° γ=90.00°
N,N'-Dithiodiphthalimide ethylbenzene/water solvate
C19.652H12.652N2O4.043S2
Acta Crystallographica Section B (2002) 58, 2 289-299
a=13.7600(4)Å b=16.4924(4)Å c=16.0450(5)Å
α=90.00° β=92.9510(10)° γ=90.00°
N,N'-Dithiophthalimide
C16H8N2O4S2
Acta Crystallographica Section B (2002) 58, 2 289-299
a=14.4180(6)Å b=16.0502(7)Å c=7.6616(3)Å
α=90.00° β=93.369(2)° γ=90.00°
N,N'-Dithiodiphthalimide
C16H8N2O4S2
Acta Crystallographica Section B (2002) 58, 2 289-299
a=14.3752(5)Å b=15.9349(10)Å c=7.631(10)Å
α=90.00° β=93.845(2)° γ=90.00°
N,N'-Dithiodiphthalimide hemi(p-xylene) solvate
C16H8N2O4S2,0.5(C8H10)
Acta Crystallographica Section B (2002) 58, 2 289-299
a=14.2629(5)Å b=16.1851(4)Å c=7.7835(2)Å
α=90.00° β=94.3917(9)° γ=90.00°
N,N'-Dithiodiphthalimide hemi(toluene) solvate
C16H8N2O4S2,0.5(C7H8)
Acta Crystallographica Section B (2002) 58, 2 289-299
a=14.3126(4)Å b=16.1270(4)Å c=7.6990(2)Å
α=90.00° β=94.3216(13)° γ=90.00°
N,N'-Dithiodiphthalimide hemi(chlorobenzene) solvate
C16H8N2O4S2,0.5(C6H5Cl1)
Acta Crystallographica Section B (2002) 58, 2 289-299
a=7.6257(10)Å b=10.3369(2)Å c=11.6392(2)Å
α=81.5440(8)° β=77.8600(8)° γ=78.8480(13)°
2-Amino-4,6-bis(pyrrolidino)-5-nitrosopyrimidine hydrate
C12H19.1N6O1.55
Acta Crystallographica Section B (2002) 58, 2 300-315
a=18.4687(8)Å b=8.1067(3)Å c=19.1880(6)Å
α=90.00° β=110.580(2)° γ=90.00°
Meso-5,7,7,12,14,14-hexamethyl-4,11-diaza-1,8-diazoniacyclotetradecane bis(3-carboxy-5-nitrobenzoate)
C16H38N42,2C8H4NO6
Acta Crystallographica Section C (2002) 58, 8 o470-o473
a=8.5183(6)Å b=10.2278(8)Å c=11.3272(9)Å
α=66.6350(10)° β=71.3870(10)° γ=82.9760(10)°
N,N'-Dimethylpiperazine--tartaric acid--water (1/2/2)
C6H16N22,2C4H5O61,2H2O
Acta Crystallographica Section C (2002) 58, 1 o6-o8
a=7.2907(3)Å b=8.3423(4)Å c=8.4324(4)Å
α=96.406(2)° β=106.359(2)° γ=90.430(3)°
Piperazinium(2+) bis(mandelate) bis(methanol) solvate
C4H12N22,2C8H7O3,2CH4O
Acta Crystallographica Section C (2001) 57, 8 955-957
a=7.7360(2)Å b=10.2394(4)Å c=29.7822(11)Å
α=90° β=90° γ=90°
N,N'-Dimethylpiperazinium (2+) phosphonoacetate
C6H16N22,2C2H4O5P
Acta Crystallographica Section C (2001) 57, 8 952-954
a=5.9217(4)Å b=8.9858(5)Å c=8.9987(6)Å
α=61.730(3)° β=81.885(3)° γ=81.448(4)°